13.17
Finanzdaten der Adaptive Biotechnologies Corp-Aktie (ADPT)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
23.72%
71.68
|
93.97 | 58.88 | 52.44 | 46.44 |
| Cost Of Revenue |
0.37%
18.22
|
18.16 | 18.00 | 16.98 | 16.67 |
| Gross Profit |
29.49%
53.46
|
75.82 | 40.88 | 35.46 | 29.77 |
|
|
1.07%
66.23
|
65.53 | 65.92 | 65.07 | 62.40 |
| Interest Income/Expense |
0.57%
2.954
|
2.971 | 2.948 | 2.905 | 2.939 |
| Benefits Costs and Expenses |
0.99%
85.26
|
84.43 | 84.47 | 82.27 | 78.53 |
| Costs And Expenses |
0.92%
84.45
|
83.68 | 83.92 | 82.05 | 79.07 |
| Depreciation and Amortization |
8.06%
3.652
|
3.972 | 4.071 | 4.731 | 4.591 |
| Operating Income/Loss |
224.13%
-12.77
|
10.29 | -25.04 | -29.60 | -32.63 |
| Income/Loss From Continuing Operations Before Tax |
242.26%
-13.58
|
9.545 | -25.59 | -29.83 | -32.10 |
| Income/Loss From Continuing Operations After Tax |
242.26%
-13.58
|
9.545 | -25.59 | -29.83 | -32.10 |
|
|
242.26%
-13.58
|
9.545 | -25.59 | -29.83 | -32.10 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
100.00%
-
|
-0.001 | 0.021 | 0.022 | -0.026 |
| Basic Average Shares |
99.69%
0.4735
|
152.43 | 152.08 | 149.20 | 147.52 |
| Diluted Average Shares |
99.71%
0.4735
|
163.16 | 152.08 | 149.20 | 147.52 |
| Basic Earnings Per Share |
250.00%
-0.09
|
0.06 | -0.17 | -0.20 | -0.22 |
| Diluted Earnings Per Share |
250.00%
-0.09
|
0.06 | -0.17 | -0.20 | -0.22 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):